Search research articles
Contact Us
Filters
Showing results (111-120 of 117) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 117 results.
Bioorganic & Medicinal Chemistry Letters
|
January 28, 2014
A novel class of ion displacement ligands as antagonists of the αIIbβ3 receptor that limit conformational reorganization of the receptor
Jian-kang Jiang, Joshua G McCoy, Min Shen, et al.
Cell
|
November 29, 2011
Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs
Miguel Fribourg, José L Moreno, Terrell Holloway, et al.
Journal of Medicinal Chemistry
|
September 10, 2021
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects
Soumen Chakraborty, Jeffrey F DiBerto, Abdelfattah Faouzi, et al.
ACS Pharmacology & Translational Science
|
April 8, 2020
Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations
Jihong Li, Yoshiyuki Fukase, Yi Shang, et al.
Nature Communications
|
February 27, 2025
Large scale investigation of GPCR molecular dynamics data uncovers allosteric sites and lateral gateways
David Aranda-García, Tomasz Maciej Stepniewski, Mariona Torrens-Fontanals, et al.
Nature Methods
|
July 15, 2020
GPCRmd uncovers the dynamics of the 3D-GPCRome
Ismael Rodríguez-Espigares, Mariona Torrens-Fontanals, Johanna K S Tiemann, et al.
Nature Methods
|
July 25, 2020
Publisher Correction: GPCRmd uncovers the dynamics of the 3D-GPCRome
Ismael Rodríguez-Espigares, Mariona Torrens-Fontanals, Johanna K S Tiemann, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 117) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 117 results.
Bioorganic & Medicinal Chemistry Letters
|
January 28, 2014
A novel class of ion displacement ligands as antagonists of the αIIbβ3 receptor that limit conformational reorganization of the receptor
Jian-kang Jiang, Joshua G McCoy, Min Shen, et al.
Cell
|
November 29, 2011
Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs
Miguel Fribourg, José L Moreno, Terrell Holloway, et al.
Journal of Medicinal Chemistry
|
September 10, 2021
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects
Soumen Chakraborty, Jeffrey F DiBerto, Abdelfattah Faouzi, et al.
ACS Pharmacology & Translational Science
|
April 8, 2020
Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations
Jihong Li, Yoshiyuki Fukase, Yi Shang, et al.
Nature Communications
|
February 27, 2025
Large scale investigation of GPCR molecular dynamics data uncovers allosteric sites and lateral gateways
David Aranda-García, Tomasz Maciej Stepniewski, Mariona Torrens-Fontanals, et al.
Nature Methods
|
July 15, 2020
GPCRmd uncovers the dynamics of the 3D-GPCRome
Ismael Rodríguez-Espigares, Mariona Torrens-Fontanals, Johanna K S Tiemann, et al.
Nature Methods
|
July 25, 2020
Publisher Correction: GPCRmd uncovers the dynamics of the 3D-GPCRome
Ismael Rodríguez-Espigares, Mariona Torrens-Fontanals, Johanna K S Tiemann, et al.
Page
of 12